Department of Surgery, Minimally Invasive Surgery Research Center, Division of Minimally Invasive and Bariatric Surgery, School of Medicine, Rasool-E Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Centre of Excellence of European Branch of International Federation for Surgery of Obesity, Hazrat_e Rasool Hospital, Tehran, Iran.
BMC Surg. 2023 Sep 9;23(1):272. doi: 10.1186/s12893-023-02175-4.
Metabolic and bariatric surgery (MBS) in patients with low body mass index patients is a topic of debate. This study aimed to address all aspects of controversies in these patients by using a worldwide survey.
An online 35-item questionnaire survey based on existing controversies surrounding MBS in class 1 obesity was created by 17 bariatric surgeons from 10 different countries. Responses were collected and analysed by authors.
A total of 543 bariatric surgeons from 65 countries participated in this survey. 52.29% of participants agreed with the statement that MBS should be offered to class-1 obese patients without any obesity related comorbidities. Most of the respondents (68.43%) believed that MBS surgery should not be offered to patients under the age of 18 with class I obesity. 81.01% of respondents agreed with the statement that surgical interventions should be considered after failure of non-surgical treatments.
This survey demonstrated worldwide variations in metabolic/bariatric surgery in patients with class 1 obesity. Precise analysis of these results is useful for identifying different aspects for future research and consensus building.
对于低体重指数患者进行代谢和减重手术（MBS）是一个有争议的话题。本研究旨在通过全球调查来解决这些患者中存在的所有争议。
由来自 10 个不同国家的 17 位减重外科医生根据围绕 1 类肥胖症的 MBS 现有争议创建了一个包含 35 个项目的在线问卷。由作者收集并分析了回复。
共有来自 65 个国家的 543 位减重外科医生参与了这项调查。52.29%的参与者同意以下说法：对于没有任何肥胖相关合并症的 1 类肥胖患者，应提供 MBS。大多数受访者（68.43%）认为不应该为年龄在 18 岁以下的 1 类肥胖患者提供 MBS 手术。81.01%的受访者同意以下说法：在非手术治疗失败后应考虑手术干预。
本调查表明，全球范围内对于 1 类肥胖症患者的代谢/减重手术存在差异。对这些结果进行精确分析有助于确定未来研究和共识建立的不同方面。
